IFNG and infection: However, as the disease progresses to a chronic active disease (G2), infection loads climb and there is a shift in the Th2 systemic response only, marked by moderate increases in systemic anti-Chlamydia IgG with no change in Th1 responses (measured by IFNγ related pathways).